AviadoBio Targets Rare Form Of Dementia With Gene Therapy
With Targeted Thalamus Delivery
The UK biotech hopes to address a fast-progressing form of dementia that affects people earlier in life with a supplemental gene therapy delivered directly to the brain’s information centre.